🧐 ProPicks AI October update is out now! See which stocks made the listPick Stocks with AI

Mexico, with over 500,000 coronavirus cases, to help with vaccine

Published 2020-08-13, 08:04 p/m
© Reuters. Outbreak of the coronavirus disease (COVID-19) in Monterrey

MEXICO CITY (Reuters) - Mexico, having hit over half a million official coronavirus cases and 55,000 deaths as the pandemic rages across Latin America, will help produce a vaccine that could be distributed in the region next year, authorities said on Thursday.

President Andres Manuel Lopez Obrador has said the pandemic is losing force in Mexico, though the death toll of 55,293 stands as the world's third highest, behind the United States and Brazil.

Mexico's health ministry on Thursday reported 7,371 new confirmed cases of coronavirus, bringing the total in the country to 505,751.

The government has said the real number of infected people is likely significantly higher than the confirmed cases.

In partnership with the Mexican and Argentine governments, pharmaceutical company AstraZeneca Plc said it plans to initially produce 150 million doses of a coronavirus vaccine in early 2021 and eventually make at least 400 million for distribution throughout the region.

Lopez Obrador hailed the agreement as "good news" for Mexico and said he expected the country to still be suffering from the pandemic by the time the vaccine goes into production.

Supporting Lopez Obrador's argument that COVID-19 is waning in Mexico, the government's head of epidemiology, Jose Luis Alomia, said on Wednesday that fewer tests were coming back positive.

© Reuters. Outbreak of the coronavirus disease (COVID-19) in Mexico City

"It's congruent with the decrease in overall cases we've seen in recent weeks" as some 47% of tests were coming back positive this week, compared to 53% to 54% three to four weeks ago, Alomia said.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.